Medicare coverage of obesity medications could drive a substantial rise in healthcare spending, according to a new study. A microsimulation model published in JAMA Health Forum projected that Medicare ...

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.

We recently published a list of 10 Best Stocks to Buy According to Billionaire Warren Buffett. In this article, we are going ...

Q1 2025 Management View CEO Dan Chard emphasized the company's focus on the evolving weight-loss market, highlighting the ...